Perkins Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Perkins Capital Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,000	Closed	-$79K	–	148
2014 Q2	$79K	Sell	10,000 -4,000	-29%	-$30.2K	0.06%	134
2014 Q1	$111K	Hold	14,000	–	–	0.08%	124
2013 Q4	$87K	Hold	14,000	–	–	0.06%	126
2013 Q3	$50K	Hold	14,000	–	–	0.04%	123
2013 Q2	$27K	Buy	+14,000	New	+$28.1K	0.02%	122

Other funds holding CORV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FIG

Fortress Investment Group New York $531M AUM 12.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Perkins Capital Management's CORV Position: Q3 2014 in Review

Perkins Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2014, closing a stake of 10,000 shares — an estimated $79K sold.

Perkins Capital Management first reported a position in CORV in Q2 2013 and held it in 5 quarters. The position peaked at $111K in Q1 2014. 27 funds tracked by Wall St. Rank hold CORV as of Q3 2014.

Perkins Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2014 after selling out during the quarter.
Perkins Capital Management sold 10,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2014, an estimated $79K.
Perkins Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 5 quarters.
Perkins Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $111K in Q1 2014.
27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2014.

Based on Perkins Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.